- Report
- January 2024
Paraguay
From €1273EUR$1,450USD£1,107GBP
- Report
- January 2024
Panama
From €1273EUR$1,450USD£1,107GBP
- Report
- February 2026
- 50 Pages
Global
From €2326EUR$2,650USD£2,024GBP
From €12728EUR$14,500USD£11,073GBP
- Report
- October 2024
Global
From €3072EUR$3,500USD£2,673GBP
- Report
- August 2024
Global
From €24139EUR$27,500USD£21,001GBP
Estradiol is a hormone used in the treatment of prostate cancer. It is a form of estrogen, and is used to reduce the levels of testosterone in the body, which can help slow the growth of prostate cancer cells. Estradiol is typically administered as an injection, and is often used in combination with other drugs to treat prostate cancer. It is also used to reduce the risk of prostate cancer recurrence after surgery. Side effects of estradiol can include hot flashes, breast tenderness, and increased risk of blood clots.
The estradiol market is a growing segment of the prostate cancer drug market. It is used in combination with other drugs to treat prostate cancer, and is increasingly being used to reduce the risk of recurrence after surgery. The market is expected to continue to grow as more patients are diagnosed with prostate cancer and the need for effective treatments increases.
Companies in the estradiol market include Pfizer, Novartis, and AstraZeneca. Show Less Read more